New study tests if GP-pharmacist teamwork can help patients quit antidepressants safely

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients will be eligible for inclusion in the study if they meet all of the following criteria: * Are 18 years or older and capable of providing informed consent. * Have their Global Medical File (GMD) managed by one of the participating GPs. * Have been prescribed AD (any type) by their GP for the treatment of depression, with: * at least 6 months of continuous daily use following a first depressive episode, or * at least 2 years of continuous daily use in the context of a relapsed depression/recurrent episode * Are judged by their GP as no longer meeting the criteria for a current depressive disorder. Exclusion Criteria: Patients will be excluded from participation in the study if they meet any of the following criteria: * AD discontinuation is considered contra-indicated by the treating GP. * The patient is judged by the GP to be at high risk of relapse. This includes any of the following: * Current significant depressive symptoms, defined as a score of ≥12 on the PHQ-9 * Current significant anxiety symptoms, defined as a score of ≥10 on the Generalised Anxiety Disorder-7 (GAD-7) scale. * Current suicidal ideation, defined as a score \>0 on item 9 (suicidality) of the PHQ-9. * The patient is currently receiving only psychiatric treatment (out- or inpatient) for depression In addition to the criteria increasing the risk of relapse, the following will also be an exclusion criteria: * The patient has a current psychiatric comorbidity (e.g. bipolar disorder, psychosis, substance use) * The patient has a diagnosis of dementia or significant cognitive impairment (assessed by GP judgement) or is living in a nursing home. * The AD is prescribed for a primary indication other than depression, such as anxiety alone without comorbid depressive disorder, or chronic pain. * The patient has insufficient language proficiency in Dutch or French to participate in the study procedures (e.g. providing consent, completion of questionnaires, interviews). * use of trazodon as AD as this is mainly used for sleep problems